Joshua Brody/X
Jul 18, 2024, 00:18
Joshua Brody: Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared on X:
“Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma with 85% complete remission rate… with thanks to the patients, families, and clinical research team at Mount Sinai Health System and around the world.”
Read further.
Source: Joshua Brody/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 07:13
Aug 24, 2025, 04:55
Aug 24, 2025, 01:32
Aug 23, 2025, 22:57
Aug 23, 2025, 22:35